Arax Advisory Partners’s Usana Health Sciences USNA Stock Holding History

Arax Advisory Partners’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.6K	Buy	1,901 +1,809	+1,966%	+$34K	﹤0.01%	3443
2026 Q1	$1.61K	Sell	92 -287	-76%	-$5.7K	﹤0.01%	3167
2025 Q4	$7.44K	Sell	379 -1,432	-79%	-$29.7K	﹤0.01%	2636
2025 Q3	$49.9K	Buy	1,811 +1,783	+6,368%	+$54.9K	﹤0.01%	1839
2025 Q2	$855	Buy	28 +6	+27%	+$170	﹤0.01%	2828
2025 Q1	$594	Buy	+22	New	+$697	﹤0.01%	2506
2024 Q4	–	Sell	-54	Closed	-$2.05K	–	2753
2024 Q3	$2.05K	Hold	54	–	–	﹤0.01%	2056
2024 Q2	$2.44K	Buy	+54	New	+$2.48K	﹤0.01%	1895

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arax Advisory Partners's USNA Position: Q2 2026 in Review

Arax Advisory Partners increased its Usana Health Sciences (USNA) stake by 1,966% in Q2 2026, buying an estimated $34K and bringing the position to 1,901 shares worth $40.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

Arax Advisory Partners first reported a position in USNA in Q2 2024 and has held it in 8 quarters since. The position peaked at $49.9K in Q3 2025. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Arax Advisory Partners held 1,901 shares of Usana Health Sciences worth $40.6K as of Q2 2026.
Arax Advisory Partners bought 1,809 Usana Health Sciences shares in Q2 2026, an estimated $34K.
Usana Health Sciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3443 holding.
Arax Advisory Partners first reported a position in Usana Health Sciences in Q2 2024 and has held it in 8 quarters since.
Arax Advisory Partners's Usana Health Sciences position peaked at $49.9K in Q3 2025.
138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.